Findings in Fluorescein Angiography and Optical Coherence Tomography after Intravitreal Bevacizumab in Type 2 Idiopathic Macular Telangiectasia
- 30 September 2007
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 114 (9) , 1736-1742
- https://doi.org/10.1016/j.ophtha.2007.03.079
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic RetinopathyPublished by Elsevier ,2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- VITREOUS LEVELS OF UNBOUND BEVACIZUMAB AND UNBOUND VASCULAR ENDOTHELIAL GROWTH FACTOR IN TWO PATIENTSRetina, 2006
- Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular DegenerationOphthalmology, 2006
- Changes in Retinal Neovascularization after Pegaptanib (Macugen) Therapy in Diabetic IndividualsOphthalmology, 2006
- Idiopathic Juxtafoveal Retinal Telangiectasis: New Findings by Ultrahigh-Resolution Optical Coherence TomographyOphthalmology, 2006
- Inhibitors of Ocular NeovascularizationJAMA, 2005
- Pegaptanib for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2004
- Vascular Endothelial Growth Factor Induces Rapid Phosphorylation of Tight Junction Proteins Occludin and Zonula Occluden 1Journal of Biological Chemistry, 1999
- Idiopathic Juxtafoveolar Retinal TelangiectasisArchives of Ophthalmology (1950), 1982